-
EP3796899
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3796899
| EP3796899 - NOVEL PHARMACEUTICAL COMPOSITION OF TAMSULOSIN AND DUTASTERIDE [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 05.07.2024 Database last updated on 31.08.2024 | |
| Former | The patent has been granted Status updated on 28.07.2023 | ||
| Former | Grant of patent is intended Status updated on 14.03.2023 | ||
| Former | Request for examination was made Status updated on 26.02.2021 | ||
| Former | The international publication has been made Status updated on 30.11.2019 | Most recent event Tooltip | 05.07.2024 | No opposition filed within time limit | published on 07.08.2024 [2024/32] | Applicant(s) | For all designated states Zim Laboratories Limited B-21/22 MIDC Area Kalmeshwar 441501 Maharashtra / IN | [2021/13] | Inventor(s) | 01 /
DAUD, Anwar B-21/22 MIDC Area, Kalmeshwar Nagpur 441 501 / IN | 02 /
ACHLIYA, Girish B-21/22 MIDC Area, Kalmeshwar Nagpur 441 501 / IN | 03 /
MASKI, Nitin B-21/22 MIDC Area, Kalmeshwar Nagpur 441 501 / IN | 04 /
WADLE, Shashikant B-21/22 MIDC Area, Kalmeshwar Nagpur 441 501 / IN | [2021/13] | Representative(s) | Freischem & Partner Patentanwälte mbB Salierring 47-53 50677 Köln / DE | [2021/13] | Application number, filing date | 19806977.5 | 20.05.2019 | [2021/13] | WO2019IN50403 | Priority number, date | IN201821018849 | 19.05.2018 Original published format: IN201821018849 | [2021/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019224840 | Date: | 28.11.2019 | Language: | EN | [2019/48] | Type: | A1 Application with search report | No.: | EP3796899 | Date: | 31.03.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.11.2019 takes the place of the publication of the European patent application. | [2021/13] | Type: | B1 Patent specification | No.: | EP3796899 | Date: | 30.08.2023 | Language: | EN | [2023/35] | Search report(s) | International search report - published on: | IN | 28.11.2019 | (Supplementary) European search report - dispatched on: | EP | 11.02.2022 | Classification | IPC: | A61K31/18, A61K47/32, A61K9/28, A61K9/48, A61K9/16, A61K31/58, A61K9/50 | [2022/11] | CPC: |
A61K31/18 (EP,US);
A61K31/473 (EP,US);
A61K31/58 (EP);
A61K9/1611 (EP);
A61K9/1617 (EP);
A61K9/1635 (EP);
A61K9/1652 (EP);
A61K9/167 (EP);
A61K9/1694 (EP,US);
A61K9/2081 (US);
A61K9/4808 (US);
A61K9/4825 (EP);
A61K9/4858 (US);
A61K9/4866 (US);
A61K9/501 (US);
A61K9/5015 (US);
A61K9/5026 (EP,US);
A61K9/5042 (EP);
| C-Set: |
A61K31/18, A61K2300/00 (EP);
A61K31/58, A61K2300/00 (EP) |
| Former IPC [2021/13] | A61K31/18, A61K47/32, A61K9/28 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/13]
| Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | NEUARTIGE PHARMAZEUTISCHE ZUSAMMENSETZUNG VON TAMSULOSIN UND DUTASTERID | [2021/13] | English: | NOVEL PHARMACEUTICAL COMPOSITION OF TAMSULOSIN AND DUTASTERIDE | [2021/13] | French: | NOUVELLE COMPOSITION PHARMACEUTIQUE DE TAMSULOSINE ET DE DUTASTÉRIDE | [2021/13] | Entry into regional phase | 23.11.2020 | National basic fee paid | 23.11.2020 | Search fee paid | 23.11.2020 | Designation fee(s) paid | 23.11.2020 | Examination fee paid | Examination procedure | 23.11.2020 | Examination requested [2021/13] | 29.08.2022 | Amendment by applicant (claims and/or description) | 15.03.2023 | Communication of intention to grant the patent | 20.07.2023 | Fee for grant paid | 20.07.2023 | Fee for publishing/printing paid | 20.07.2023 | Receipt of the translation of the claim(s) | Opposition(s) | 03.06.2024 | No opposition filed within time limit [2024/32] | Fees paid | Renewal fee | 08.05.2021 | Renewal fee patent year 03 | 17.05.2022 | Renewal fee patent year 04 | 23.05.2023 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]EP2468262 (KRKA TOVARNA ZDRAVIL D D NOVO MESTO [SI]) [I] 1-19 * paragraph [0049]; claim 1 * * paragraphs [0047] , [0050]; claims 10,11 * * paragraphs [0094] - [0097] - [0102] - [0104]; examples 1-3,7,8 * * paragraphs [0098] - [0100]; examples 4-6 *; | [A]US2016074333 (DABRE RAHUL SUDHAKAR [IN], et al) [A] 1-19 * paragraphs [0093] - [0098]; claim 1 * * paragraphs [0104] - [0109]; example 1 * * paragraph [0110]; example 3 ** claims 11,12 * | International search | [A]EP2468262 (KRKA TOVARNA ZDRAVIL D D NOVO MESTO [SI]) [A] 1-19* examples 1-6 *; | [A]WO2016003180 (HANMI PHARM IND CO LTD [KR]) [A] 1-19 * claims 1-15 and para [83] * |